Petros Pharma 10-Q: Warrant Fair Value Inputs Detailed
Ticker: PTPI · Form: 10-Q · Filed: May 15, 2025 · CIK: 1815903
| Field | Detail |
|---|---|
| Company | Petros Pharmaceuticals, Inc. (PTPI) |
| Form Type | 10-Q |
| Filed Date | May 15, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, warrants, valuation
Related Tickers: PTPI
TL;DR
PTPI 10-Q shows warrant valuation inputs as of 3/31/25. #finance
AI Summary
Petros Pharmaceuticals, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial information, including fair value adjustments for warrants. Key inputs for these adjustments as of March 31, 2025, include risk-free interest rates, price volatility, expected term, expected dividend rate, and exercise price.
Why It Matters
This filing provides insight into the financial instruments and valuation methods used by Petros Pharmaceuticals, which can impact investor understanding of the company's financial health and potential liabilities.
Risk Assessment
Risk Level: medium — The filing discusses financial instruments and valuation inputs, which can be complex and subject to market fluctuations, indicating a medium level of financial risk.
Key Numbers
- 0.04 — Fair Value Adjustment of Warrants (Represents a financial adjustment related to warrants.)
- 12.00 — N/A (This number appears without clear context in the provided snippet.)
- 0.25 — N/A (This number appears without clear context in the provided snippet.)
Key Players & Entities
- Petros Pharmaceuticals, Inc. (company) — Filer of the 10-Q
- March 31, 2025 (date) — End of the reporting period
- 1185 AVENUE OF THE AMERICAS, 3RD FLOOR (address) — Business and mailing address
- 973-242-0005 (phone_number) — Business phone number
FAQ
What is the specific nature of the 'Fair Value Adjustment of Warrants' mentioned?
The filing indicates a 'Fair Value Adjustment of Warrants' with a value of $0.04, related to 'ptpi:SeriesPreferredWarrantsMember'.
What are the key inputs used for the fair value measurement of warrants as of March 31, 2025?
The key inputs include risk-free interest rate, price volatility, expected term, expected dividend rate, and exercise price.
What is the fiscal year end for Petros Pharmaceuticals, Inc.?
The fiscal year end for Petros Pharmaceuticals, Inc. is December 31.
What is the SEC file number for Petros Pharmaceuticals, Inc.?
The SEC file number for Petros Pharmaceuticals, Inc. is 001-39752.
What is the SIC code for Petros Pharmaceuticals, Inc.?
The Standard Industrial Classification (SIC) code for Petros Pharmaceuticals, Inc. is 2834 (Pharmaceutical Preparations).
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 15, 2025 regarding Petros Pharmaceuticals, Inc. (PTPI).